您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > BQ-3020(trifluoroacetate salt)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BQ-3020(trifluoroacetate salt)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BQ-3020(trifluoroacetate salt)图片
规格:98%
分子量:2006.3
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
A peptide ETB receptor antagonist
货号:ajcx26686
CAS:N/A
分子式:C96H140N20O25S • XCF3COOH
分子量:2006.3
溶解度:DMSO: 25 mg/ml,DMSO:PBS (pH 7.2) (1:3): 0.25 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

BQ-3020 is a peptide endothelin type B (ETB) receptor agonist.1It selectively binds to ETBover ETAreceptors (IC50s = 0.07 and 940 nM, respectively) and induces inositol triphosphate formation and calcium mobilization in isolated bovine carotid artery endothelial cells.1,2BQ-3020 increases or decreases renal perfusion pressure in Dahl salt-resistant or -sensitive rats, respectively.3It decreases the production of nitric oxide (NO) and induces vasoconstriction in a rat model of diet-induced hypercholesterolemia.

1.Ihara, M., Saek, T., Fukuroda, T., et al.A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptorsLife Sci.51(6)PL47-PL52(1992) 2.Hirata, Y., Emori, T., Eguchi, S., et al.Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cellsJ. Clin. Invest.91(4)1367-1373(1993) 3.Kakoki, M., Hirata, Y., Hayakawa, H., et al.Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidneyCirculation99(9)1242-1248(1999)